PHIBRO ANIMAL HEALTH CORP (PAHC)

Data as of Sep 17, 2026, from SEC Form 4 filings.

No open-market insider trades (90d)Watch PAHC

See up to 3 months of PAHC. The 7-day demo opens the 1M and 3M ranges and puts PAHC on your watchlist.

Latest PAHC insider trades

E. Thomas Corcoran - Director
Open-market purchase$318K
May 29, 2026
Jack Bendheim - Officer
Open-market sale$349K

About PHIBRO ANIMAL HEALTH CORP (PAHC)

PHIBRO ANIMAL HEALTH CORP files with the SEC under CIK 0001069899 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.

Sector: Health Care

SEC filings for PAHC on EDGAR

PAHC Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Grant or award	10	46,110
Other acquisition / disposition	6	5,001

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

PAHC insider transactions (Form 4)

59 Form 4 filings on record, the earliest from Aug 15, 2025, newest first. Filing history page 2 of 2.

Date	Insider	Transaction	Security	Shares	Price	Value
Feb 9, 2026	Glenn David - Officer	Option exercise	Class A Common Stock	30,000	-^{footnote F1}	-
Feb 11, 2026	Glenn David - Officer	Other	Class A Common Stock	12,528^{footnote F2}	$51.63^{footnote F3}	$647K
Feb 9, 2026	Glenn David - Officer	Option exercise	Restricted Stock Units	30,000	$0.00	-
Footnote F1 (price): Shares were issued in settlement of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. Footnote F2 (shares): Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of the RSUs. Footnote F3 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.54 to $52.03. The reporting person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff… Full note on SEC EDGAR
Feb 5, 2026	Jack Bendheim - Officer	Other	Class A Common Stock	185,000	$0.00	-
Feb 5, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	409	$44.47^{footnote F4}	$18K
Feb 5, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,640	$45.42^{footnote F5}	$165K
Feb 5, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,171	$46.68^{footnote F6}	$148K
Feb 5, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	38,209	$47.91^{footnote F7}	$1.83M
Feb 5, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	46,275	$48.65^{footnote F8}	$2.25M
Feb 5, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	19,138	$49.57^{footnote F9}	$949K
Feb 5, 2026	Jack Bendheim - Officer	Other	Class B Common Stock	185,000	$0.00	-
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.035 to $44.73. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange… Full note on SEC EDGAR Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.04 to $46.02. Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.10 to $47.08. Footnote F7 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.17 to $48.17. Footnote F8 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.175 to $49.17. Footnote F9 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.18 to $50.01.
Feb 3, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	6,689	$41.25^{footnote F2}	$276K
Feb 3, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	2,971	$41.97^{footnote F4}	$125K
Feb 4, 2026	Jack Bendheim - Officer	Other	Class A Common Stock	30,000	$0.00	-
Feb 4, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,520	$41.15^{footnote F6}	$145K
Feb 4, 2026	Jack Bendheim - Officer	Other	Class B Common Stock	30,000	$0.00	-
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.69 to $41.68. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff… Full note on SEC EDGAR Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.70 to $42.62. Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.535 to $41.52.
Jan 29, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	6,772	$40.12^{footnote F2}	$272K
Jan 30, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	6,693	$40.09^{footnote F4}	$268K
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.475. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the… Full note on SEC EDGAR Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.365.
Jan 23, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	1,235	$40.55^{footnote F2}	$50K
Jan 26, 2026	Jack Bendheim - Officer	Other	Class A Common Stock	30,000	$0.00	-
Jan 26, 2026	Jack Bendheim - Officer	Other	Class B Common Stock	30,000	$0.00	-
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.175 to $41.01. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the… Full note on SEC EDGAR
Jan 21, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	14,687	$41.68^{footnote F2}	$612K
Jan 22, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	11,875	$41.91^{footnote F4}	$498K
Jan 22, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	1,283	$42.68^{footnote F5}	$55K
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.11 to $42.02. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff… Full note on SEC EDGAR Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.58 to $42.53. Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.62 to $42.77.
Jan 13, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	7,551	$40.32^{footnote F2}	$304K
Jan 14, 2026	Jack Bendheim - Officer	Other	Class A Common Stock	20,000	$0.00	-
Jan 14, 2026	Jack Bendheim - Officer	Other	Class B Common Stock	20,000	$0.00	-
Jan 14, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,258	$40.46^{footnote F5}	$132K
Jan 14, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	393	$41.14^{footnote F6}	$16K
Jan 15, 2026	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	2,932	$40.02^{footnote F7}	$117K
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.09 to $40.51. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff… Full note on SEC EDGAR Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.025 to $40.985. Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.125 to $41.15. Footnote F7 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.07.
Dec 3, 2025	Jack Bendheim - Officer	Other	Class A Common Stock	30,000	$0.00	-
Dec 3, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,520	$40.77^{footnote F4}	$144K
Dec 4, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,152	$41.16^{footnote F5}	$130K
Dec 4, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	368	$41.75^{footnote F6}	$15K
Dec 3, 2025	Jack Bendheim - Officer	Other	Class B Common Stock	30,000	$0.00	-
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.30 to $41.12. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange… Full note on SEC EDGAR Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.73 to $41.72. Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.73 to $41.775.
Nov 28, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,520	$42.54^{footnote F2}	$150K
Dec 1, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,520	$41.66^{footnote F4}	$147K
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.12 to $43.02. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff… Full note on SEC EDGAR Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.38 to $41.895.
Nov 25, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	7,040	$43.93^{footnote F2}	$309K
Nov 26, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	5,280	$44.02^{footnote F4}	$232K
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.51 to $44.195. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the… Full note on SEC EDGAR Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.79 to $44.37.
Nov 20, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,459	$41.75^{footnote F2}	$144K
Nov 20, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	61	$42.32	$3K
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.29 to $42.25. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff… Full note on SEC EDGAR
Nov 18, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	5,260	$43.82^{footnote F5}	$230K
Nov 18, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	20	$44.28	$886
Nov 14, 2025	Jack Bendheim - Officer	Other	Class B Common Stock	55,000	$0.00	-
Nov 14, 2025	Jack Bendheim - Officer	Other	Class A Common Stock	55,000	$0.00	-
Nov 17, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	5,280	$44.56^{footnote F4}	$235K
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.24 to $44.96. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange… Full note on SEC EDGAR Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.27 to $44.26.
Nov 13, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	7,147	$44.37^{footnote F5}	$317K
Nov 13, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	1,654	$44.93^{footnote F6}	$74K
Nov 11, 2025	Jack Bendheim - Officer	Other	Class B Common Stock	15,000	$0.00	-
Nov 11, 2025	Jack Bendheim - Officer	Other	Class A Common Stock	15,000	$0.00	-
Nov 12, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	21,536	$45.23^{footnote F4}	$974K
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.95 to $45.85. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange… Full note on SEC EDGAR Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.84 to $44.78. Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.86 to $45.465.
Nov 10, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	14,086	$44.91^{footnote F5}	$633K
Nov 10, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	19,773	$45.81^{footnote F6}	$906K
Nov 10, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	320	$46.36^{footnote F7}	$15K
Nov 7, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,520	$42.86^{footnote F2}	$151K
Nov 10, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	4,124	$44.00^{footnote F4}	$181K
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.61 to $43.195. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the… Full note on SEC EDGAR Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.31 to $44.28. Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.31 to $45.26. Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.33 to $46.32. Footnote F7 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.355 to $46.36.
Nov 5, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	2,548	$40.98^{footnote F6}	$104K
Nov 5, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	972	$41.83^{footnote F7}	$41K
Nov 4, 2025	Jack Bendheim - Officer	Other	Class B Common Stock	25,000	$0.00	-
Nov 4, 2025	Jack Bendheim - Officer	Other	Class A Common Stock	25,000	$0.00	-
Nov 4, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	2,996	$43.01^{footnote F4}	$129K
Nov 4, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	524	$43.62^{footnote F5}	$23K
Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.49 to $43.48. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange… Full note on SEC EDGAR Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.555 to $43.705. Footnote F6 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.65 to $41.535. Footnote F7 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.67 to $42.14.
Oct 29, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,520	$41.66^{footnote F4}	$147K
Oct 30, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,520	$41.07^{footnote F5}	$145K
Oct 28, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,520	$41.56^{footnote F2}	$146K
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.21 to $41.935. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the… Full note on SEC EDGAR Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.33 to $41.94. Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.71 to $41.30.
Oct 23, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,520	$40.18^{footnote F4}	$141K
Oct 24, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,520	$41.75^{footnote F5}	$147K
Oct 22, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	11,859	$40.27^{footnote F2}	$478K
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $41.555. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the… Full note on SEC EDGAR Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.46. Footnote F5 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.265 to $42.28.
Oct 20, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	16,075	$40.38^{footnote F4}	$649K
Oct 21, 2025	Jack Bendheim - Officer	Other	Class A Common Stock	50,000	$0.00	-
Oct 21, 2025	Jack Bendheim - Officer	Other	Class B Common Stock	50,000	$0.00	-
Oct 17, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	700	$40.03^{footnote F2}	$28K
Footnote F2 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.07. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff… Full note on SEC EDGAR Footnote F4 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.59.
Sep 30, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	20,664	$40.38	$834K
Sep 18, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	7,022	$40.26	$283K
Sep 19, 2025	Jack Bendheim - Officer	Other	Class A Common Stock	30,000	$0.00	-
Sep 19, 2025	Jack Bendheim - Officer	Other	Class B Common Stock	30,000	$0.00	-
Sep 9, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	14,080	$40.33	$568K
Sep 10, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,520	$41.29	$145K
Sep 11, 2025	Jack Bendheim - Officer	Open-market sale	Class A Common Stock	3,520	$40.95	$144K
Aug 15, 2025	Larry Lee Miller - Officer	Grant or award	Class A Common Stock	5,184	$0.00	-
Aug 15, 2025	Judith Weinstein - Officer	Grant or award	Class A Common Stock	3,447	$0.00	-
Aug 15, 2025	Glenn David - Officer	Grant or award	Class A Common Stock	4,845	$0.00	-
Aug 15, 2025	Jonathan Bendheim - Director	Grant or award	Class A Common Stock	3,268	$0.00	-
Aug 15, 2025	Daniel M. Bendheim - Officer	Grant or award	Class A Common Stock	3,964	$0.00	-
Aug 15, 2025	Jack Bendheim - Officer	Grant or award	Class A Common Stock	16,840	$0.00	-
Aug 15, 2025	Lisa Ann Escudero - Officer	Grant or award	Class A Common Stock	2,152	$0.00	-
Aug 15, 2025	Anthony Andolino - Officer	Grant or award	Class A Common Stock	1,793	$0.00	-

Recent PAHC Form 8-K filings

Read PAHC company news

Aug 26, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Jul 28, 2026Item 8.01, 9.01

Read the filing on SEC EDGAR

Jun 26, 2026Item 5.02

Read the filing on SEC EDGAR

May 6, 2026Item 2.02, 9.01

Read the filing on SEC EDGAR

Recent PAHC Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Sep 16, 2026	BFI Co. LLC	10% Stockholder	350,000	$12.36M	View on EDGAR
Aug 4, 2026	Bendheim Daniel M	Officer	486

PAHC insider trading FAQ

What is the latest insider trade for PAHC?

PHIBRO ANIMAL HEALTH CORP (PAHC) had 16 insider filings in the last 90 days, with the most recent on 2026-09-17. The full record for PAHC runs to 59 Form 4 filings, the earliest from 2025-08-15. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying PAHC stock?

No insider purchases of PAHC were filed in the last 90 days. 1 purchase is on record for this company.

How many insiders are selling PAHC stock?

No insider sales of PAHC were filed in the last 90 days. 116 sales are on record for this company.

Where can I see PAHC SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects PAHC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Sep 17, 2026 - Glenn David view on EDGAR
Sep 17, 2026 - Larry Lee Miller view on EDGAR
Aug 10, 2026 - Patrick Rodriguez view on EDGAR
Aug 10, 2026 - Glenn David view on EDGAR
Aug 10, 2026 - Larry Lee Miller view on EDGAR
Aug 10, 2026 - Jonathan Bendheim view on EDGAR
Aug 10, 2026 - Judith Weinstein view on EDGAR
Aug 10, 2026 - Jack Bendheim view on EDGAR
Aug 10, 2026 - Lisa Ann Escudero view on EDGAR

Related companies with recent insider activity

Learn more

What the Form 4 transaction codes mean: Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where PAHC's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow PAHC with a 7-day demo

PAHC on your watchlist
Every PAHC Form 4 filing on record
Up to 3 months of PAHC price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Grant or award

46,110

Other acquisition / disposition

5,001

Date

Insider

Transaction

Security

Price

Value

Feb 9, 2026

Glenn David - Officer

Option exercise

Class A Common Stock

30,000

-^{footnote F1}

Feb 11, 2026

Glenn David - Officer

Other

Class A Common Stock

12,528^{footnote F2}

$51.63^{footnote F3}

$647K

Feb 9, 2026

Glenn David - Officer

Option exercise

Restricted Stock Units

30,000

$0.00

Footnote F1 (price): Shares were issued in settlement of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock.
Footnote F2 (shares): Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of the RSUs.
Footnote F3 (price): The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.54 to $52.03. The reporting person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff… Full note on SEC EDGAR

Feb 5, 2026